UBS Group’s HeartCore Enterprises HTCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-180
Closed -$806 10698
2026
Q1
$806 Sell
180
-302
-63% -$1.62K ﹤0.01% 9728
2025
Q4
$2.94K Buy
482
+416
+630% +$5.09K ﹤0.01% 9182
2025
Q3
$1.07K Sell
66
-1,527
-96% -$21.1K ﹤0.01% 9442
2025
Q2
$15.6K Buy
+1,593
New +$18.7K ﹤0.01% 8603
2024
Q4
Sell
-138
Closed -$2.34K 10128
2024
Q3
$2.34K Buy
+138
New +$1.93K ﹤0.01% 8454
2023
Q3
Sell
-231
Closed -$6.59K 9670
2023
Q2
$6.59K Buy
231
+226
+4,520% +$5.74K ﹤0.01% 7352
2023
Q1
$91 Sell
5
-92
-95% -$1.92K ﹤0.01% 9261
2022
Q4
$1.76K Sell
97
-188
-66% -$4.21K ﹤0.01% 9802
2022
Q3
$7K Buy
285
+231
+428% +$10.5K ﹤0.01% 8873
2022
Q2
$3K Buy
+54
New +$2.02K ﹤0.01% 9319

Other funds holding HTCR

UBS Group's HTCR Position: Q2 2026 in Review

UBS Group sold out of HeartCore Enterprises (HTCR) in Q2 2026, closing a stake of 180 shares — an estimated $806 sold.

UBS Group first reported a position in HTCR in Q2 2022 and held it in 10 quarters. The position peaked at $15.6K in Q2 2025. 1 fund tracked by Wall St. Rank holds HTCR as of Q2 2026.

  • UBS Group reported no remaining HeartCore Enterprises position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 180 HeartCore Enterprises shares in Q2 2026, an estimated $806.
  • UBS Group first reported a position in HeartCore Enterprises in Q2 2022 and held it in 10 quarters.
  • UBS Group's HeartCore Enterprises position peaked at $15.6K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held HeartCore Enterprises as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.